摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[3-(3-羟丙基)苯氧基]丁酸乙酯 | 1034020-28-4

中文名称
4-[3-(3-羟丙基)苯氧基]丁酸乙酯
中文别名
——
英文名称
ethyl 4-[3-(3-hydroxypropyl)phenoxy]butanoate
英文别名
——
4-[3-(3-羟丙基)苯氧基]丁酸乙酯化学式
CAS
1034020-28-4
化学式
C15H22O4
mdl
——
分子量
266.337
InChiKey
VJWRKGCVDNXCED-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    19
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    55.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-[3-(3-羟丙基)苯氧基]丁酸乙酯三乙胺 、 sodium hydroxide 作用下, 以 乙醇甲苯 为溶剂, 反应 40.0h, 生成 ethyl 4-{3-[3-(3-benzhydryl-6-oxo-1,6-dihydropyridazin-1-yl)propyl]phenoxy}butanoate
    参考文献:
    名称:
    Development of a Practical and Scalable Synthesis of a Potent CRTH2 Antagonist
    摘要:
    This contribution describes the process research and development of a practical and scalable synthetic method towards compound 1, which has a potent CRTH2 antagonistic activity. The medicinal chemistry synthetic route and second generation synthetic route had several issues in scale-up synthesis. In contrast, the synthetic method described here does not require purification by column chromatography for all steps, and the formation of impurities is suppressed well. This highly efficient and scalable process was successfully demonstrated in the large-scale synthesis of 1.
    DOI:
    10.1021/op3001492
  • 作为产物:
    描述:
    参考文献:
    名称:
    Development of a Practical and Scalable Synthesis of a Potent CRTH2 Antagonist
    摘要:
    This contribution describes the process research and development of a practical and scalable synthetic method towards compound 1, which has a potent CRTH2 antagonistic activity. The medicinal chemistry synthetic route and second generation synthetic route had several issues in scale-up synthesis. In contrast, the synthetic method described here does not require purification by column chromatography for all steps, and the formation of impurities is suppressed well. This highly efficient and scalable process was successfully demonstrated in the large-scale synthesis of 1.
    DOI:
    10.1021/op3001492
点击查看最新优质反应信息

文献信息

  • POLYCYCLIC ACID COMPOUNDS USEFUL AS CRTH2 ANTAGONISTS AND ANTIALLERGIC AGENTS
    申请人:Terasaka Tadashi
    公开号:US20100009991A1
    公开(公告)日:2010-01-14
    The present invention relates to a novel compound or a salt thereof, which is useful as a CRTH2 antagonist, especially as a medicament for disorder that participates eosinophil, for example, allergic disorder such as asthma, allergic rhinitis, allergic dermatitis, conjunctival inflammation, hives, eosinophilic bronchitis, food allergy, inflammation of the nasal sinuses, multiple sclerosis, angiitis, or chronic obstructive pulmonary disease (COPD) and the like.
    本发明涉及一种新型化合物或其盐,该化合物可作为CRTH2拮抗剂使用,特别是作为治疗参与嗜酸性粒细胞的疾病的药物,例如哮喘、过敏性鼻炎、过敏性皮炎、结膜炎、荨麻疹、嗜酸性支气管炎、食物过敏、鼻窦炎炎症、多发性硬化症、血管炎或慢性阻塞性肺疾病(COPD)等疾病。
  • US8273745B2
    申请人:——
    公开号:US8273745B2
    公开(公告)日:2012-09-25
  • [EN] POLYCYCLIC ACID COMPOUNDS USEFUL AS CRTH2 ANTAGONISTS AND ANTIALLERGIC AGENTS<br/>[FR] NOUVEAU COMPOSÉ D' OXYCARBONYLE
    申请人:ASTELLAS PHARMA INC
    公开号:WO2008072784A1
    公开(公告)日:2008-06-19
    [EN] The present invention relates to a novel compound or a salt thereof, which is useful as a CRTH2 antagonist, especially as a medicament for disorder that participates eosinophil, for example, allergic disorder such as asthma, allergic rhinitis, allergic dermatitis, conjunctival inflammation, hives, eosinophilic bronchitis, food allergy, inflammation of the nasal sinuses, multiple sclerosis, angiitis, or chronic obstructive pulmonary disease (COPD) and the like.
    [FR] La présente invention concerne un nouveau composé ou un de ses sels, qui est utile comme antagoniste du CRTH2, en particulier comme médicament destiné au traitement d'un trouble lié aux éosinophiles, tel qu'un trouble allergique comme l'asthme, la rhinite allergique, la dermatite allergique, la conjonctivite, l'urticaire, la bronchite à éosinophiles, l'allergie alimentaire, l'inflammation des sinus paranasaux, la sclérose en plaques, l'angéite ou la maladie pulmonaire obstructive chronique (MPOC) et analogue, par exemple.
  • Development of a Practical and Scalable Synthesis of a Potent CRTH2 Antagonist
    作者:Shinya Yoshida、Toshitaka Yoshino、Akio Miyafuji、Hironobu Yasuda、Takenori Kimura、Takumi Takahashi、Takashi Mukuta
    DOI:10.1021/op3001492
    日期:2012.9.21
    This contribution describes the process research and development of a practical and scalable synthetic method towards compound 1, which has a potent CRTH2 antagonistic activity. The medicinal chemistry synthetic route and second generation synthetic route had several issues in scale-up synthesis. In contrast, the synthetic method described here does not require purification by column chromatography for all steps, and the formation of impurities is suppressed well. This highly efficient and scalable process was successfully demonstrated in the large-scale synthesis of 1.
查看更多